A Study of Belimumab in Subjects With Systemic Lupus Erythematosus
Completed · Phase 3 · Has a placebo group
Conditions studied: Systemic Lupus Erythematosus
In brief
The purpose of this study is to evaluate the efficacy, safety, tolerability, and impact on quality of life of two different doses of belimumab administered in addition to standard therapy in subjects with active, autoantibody-positive systemic lupus erythematosus (SLE) disease.
Key facts
- Study ID
- NCT00410384
- Run by
- Human Genome Sciences Inc.
- People needed
- 819
- Starts
- 2006-12-01
- Expected to finish
- 2010-03-01
- Last updated by the study team
- 2017-02-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Arizona Arthritis and Rheumatology Research, PPLC — Paradise Valley, Arizona, United States
- The University of Arizona Arthritis Center — Tucson, Arizona, United States
- Talbert Medical Group — Huntington Beach, California, United States
- Valerius Medical Group & Research Ctr of Greater Long Beach, Inc. — Long Beach, California, United States
- University of Southern California — Los Angeles, California, United States
- Wallace Rheumatic Study Center — Los Angeles, California, United States
- UCLA Rheumatology — Los Angeles, California, United States
- Arthritis Care Center, Inc. — San Jose, California, United States
- Inland Rheumatic Disease Specialties — Upland, California, United States
- Arthritis Associates of Colorado Springs — Colorado Springs, Colorado, United States
- Washington Hospital Center — Washington D.C., District of Columbia, United States
- Arthritis and Rheumatic Disease Specialties — Aventura, Florida, United States
- University of Miami-Division of Rheumatology and Immunology — Miami, Florida, United States
- Rheumatology Associates of Central Florida — Orlando, Florida, United States
- Southwest Florida Clinical Research Center — Tampa, Florida, United States
- Tampa Medical Group, P.A. — Tampa, Florida, United States
- Emory University — Atlanta, Georgia, United States
- Selah Medical Clinical Research Unit — Boise, Idaho, United States
- Rheumatology Associates, SC — Chicago, Illinois, United States
- University of Chicago Hospitals — Chicago, Illinois, United States
- Medical Specialists Clinical Research — Munster, Indiana, United States
- Kansas University Medical Center — Kansas City, Kansas, United States
- Kentuckiana Center for Better Bone and Joint Health — Louisville, Kentucky, United States
- Ochsner Clinic Foundation — Baton Rouge, Louisiana, United States
- University of Alabama at Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.